What does MEDI-NOUR do?

MEDI-NOUR is a specialist medical practice in Wemmel. Private Limited, started on 25 January 2006, 1 establishment.

What is the address of MEDI-NOUR?

The registered office of MEDI-NOUR is located at Rode Beukenlaan 8, 1780 Wemmel.

Is MEDI-NOUR still active?

Yes. According to the CBE (2 November 2026) MEDI-NOUR is active, legal situation “Normale toestand”, started on 25 January 2006.

Is MEDI-NOUR registered on Peppol?

Yes, MEDI-NOUR is registered on the Peppol network with ID 0208:0878890076.

What is the enterprise number of MEDI-NOUR?

The enterprise number of MEDI-NOUR is BE0878890076.

When was MEDI-NOUR founded?

MEDI-NOUR was founded on 25 January 2006.

Who are the directors of MEDI-NOUR?

According to the 2025 annual accounts, the directors of MEDI-NOUR are: Tayeb Sekhara.

Is MEDI-NOUR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 January 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDI-NOUR make in 2025?

MEDI-NOUR posted a profit after taxes of € 186,212 in financial year 2025.

What is the revenue of MEDI-NOUR?

As a small company, MEDI-NOUR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 370,567.

MEDI-NOUR (Private Limited) - Wemmel - BE0878890076

Dossier MEDI-NOUR, printed on 2 November 2026 from databakkes.be/en/0878890076/medi-nour. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDI-NOUR from Wemmel, company number BE0878890076, closed financial year 2025 with a result of € 186,212 after tax. For that financial year MEDI-NOUR recorded a gross margin of € 370,567 and equity of € 683,278. Compared with financial year 2024, the result moved from € 171,685 to € 186,212. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Growing

€ 683,278

▲ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 186,212

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 255,580

▲ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

27 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 60,098

▲ € 45,457 vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 64,238

▲ € 56,748 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 19,541

▼ 49% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,795

▼ 40% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 59,147

▲ 125% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 219,210 Gross margin 2022: € 219,210 First fiscal year in the series	€ 202,108 Gross margin 2023: € 202,108 ▼ 8% vs 2022 (€ 219,210) Unfavourable step	€ 295,648 Gross margin 2024: € 295,648 ▲ 46% vs 2023 (€ 202,108) Favourable step	€ 370,567 Gross margin 2025: € 370,567 ▲ 25% vs 2024 (€ 295,648) Favourable step	▲ 25%
Profit after taxes	€ 139,790 Profit after taxes 2022: € 139,790 First fiscal year in the series	€ 118,698 Profit after taxes 2023: € 118,698 ▼ 15% vs 2022 (€ 139,790) Unfavourable step	€ 171,685 Profit after taxes 2024: € 171,685 ▲ 45% vs 2023 (€ 118,698) Favourable step	€ 186,212 Profit after taxes 2025: € 186,212 ▲ 8% vs 2024 (€ 171,685) Favourable step	▲ 8%
Equity	€ 256,652 Equity 2022: € 256,652 First fiscal year in the series	€ 375,381 Equity 2023: € 375,381 ▲ 46% vs 2022 (€ 256,652) Favourable step	€ 547,066 Equity 2024: € 547,066 ▲ 46% vs 2023 (€ 375,381) Favourable step	€ 683,278 Equity 2025: € 683,278 ▲ 25% vs 2024 (€ 547,066) Favourable step	▲ 25%
Total debts	€ 119,075 Total debts 2022: € 119,075 First fiscal year in the series	€ 96,818 Total debts 2023: € 96,818 ▼ 19% vs 2022 (€ 119,075) Favourable step	€ 67,261 Total debts 2024: € 67,261 ▼ 31% vs 2023 (€ 96,818) Favourable step	€ 120,483 Total debts 2025: € 120,483 ▲ 79% vs 2024 (€ 67,261) Unfavourable step	▲ 79%
Cash	€ 159,152 Cash 2022: € 159,152 First fiscal year in the series	€ 46,872 Cash 2023: € 46,872 ▼ 71% vs 2022 (€ 159,152) Unfavourable step	€ 160,826 Cash 2024: € 160,826 ▲ 243% vs 2023 (€ 46,872) Favourable step	€ 255,580 Cash 2025: € 255,580 ▲ 59% vs 2024 (€ 160,826) Favourable step	▲ 59%
Land & buildings	€ 58,913 Land & buildings 2022: € 58,913 First fiscal year in the series	€ 39,806 Land & buildings 2023: € 39,806 ▼ 32% vs 2022 (€ 58,913) Unchanged	€ 20,699 Land & buildings 2024: € 20,699 ▼ 48% vs 2023 (€ 39,806) Unchanged	€ 1,592 Land & buildings 2025: € 1,592 ▼ 92% vs 2024 (€ 20,699) Unchanged	▼ 92%
Retained profit	€ 244,252 Retained profit 2022: € 244,252 First fiscal year in the series	€ 362,981 Retained profit 2023: € 362,981 ▲ 49% vs 2022 (€ 244,252) Favourable step	€ 534,666 Retained profit 2024: € 534,666 ▲ 47% vs 2023 (€ 362,981) Favourable step	€ 670,878 Retained profit 2025: € 670,878 ▲ 25% vs 2024 (€ 534,666) Favourable step	▲ 25%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2025: € 50,000 Unchanged (€ 0) Unchanged
Bank debt	€ 92,819 Bank debt 2022: € 92,819 First fiscal year in the series	€ 64,613 Bank debt 2023: € 64,613 ▼ 30% vs 2022 (€ 92,819) Favourable step	€ 37,946 Bank debt 2024: € 37,946 ▼ 41% vs 2023 (€ 64,613) Favourable step	€ 19,541 Bank debt 2025: € 19,541 ▼ 49% vs 2024 (€ 37,946) Favourable step	▼ 49%
Balance sheet total	€ 375,727 Balance sheet total 2022: € 375,727 First fiscal year in the series	€ 472,199 Balance sheet total 2023: € 472,199 ▲ 26% vs 2022 (€ 375,727) Unchanged	€ 614,327 Balance sheet total 2024: € 614,327 ▲ 30% vs 2023 (€ 472,199) Unchanged	€ 803,762 Balance sheet total 2025: € 803,762 ▲ 31% vs 2024 (€ 614,327) Unchanged	▲ 31%

Key figures of MEDI-NOUR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDI-NOUR?

What happened at MEDI-NOUR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 186,212 (▲ 8% vs 2024). filed late Source: NBB ↗
Jan 25, 2006 New establishment in Wemmel. KBO
Jan 25, 2006 Start of the company according to the CBE. KBO

In short

From € 139,790 profit in 2022 to € 186,212 profit in 2025.

Paid € 190,867 in corporate taxes since 2022.

Best year ever: 2025, with € 186,212 profit.

Paid out € 50,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Tayeb Sekhara

MEDI-NOUR

Behind MEDI-NOUR is Tayeb Sekhara.

Directors

According to the 2025 annual accounts

Tayeb Sekhara

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rode Beukenlaan 8

1780 Wemmel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0878.890.076
VAT number: BE 0878.890.076
Registered office: Rode Beukenlaan 8, 1780 Wemmel
Names & denominations: MEDI-NOUR
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 January 2006
Peppol: Active · Active since 25 Mar 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗